News: Distribution Agreement, Animal HealthBioniche Animal Health and IMV Technologies Sign European Distribution Agreement
16:00 EST Tuesday, December 21, 2010
- agreement also provides market planning support for India -
BELLEVILLE, ON, Dec. 21 /CNW/ - Bioniche Life Sciences Inc. (TSX: BNC),a research-based, technology-driven Canadian biopharmaceutical company,today announced that its Animal Health division has signed an agreementwith IMV Technologies (France) for the exclusive distribution of aBioniche cattle reproduction product and a select group of embryotransfer media products in Europe (excluding Spain, the UK andIreland). This agreement extends to India, where IMV will assistBioniche in the development of marketing plans for that jurisdiction.
"This alliance provides Bioniche Animal Health with enhanced access tothe rapidly expanding cattle reproduction market in continentalEurope," said Andrew Grant, Divisional President of Bioniche AnimalHealth Export Sales, Europe and A/Asia. "This relationship will allowus to sell our Folltropin®-V and embryo transfer media products in a more streamlined fashion, withIMV Technologies having an established presence and renowned expertisein animal reproduction."
"We look forward to this alliance in Europe where the in vitro fertilization segment is receiving growing interest from the industry,"said Olivier Couture, VP, Marketing (Bovine) with IMV Technologies."The association of IMV, the world leader in animal healthbiotechnology, with Bioniche Life Sciences, an expert in thepharmaceutical management of cattle reproductive performance, willprovide the embryo transfer specialist with unparalleled support. Theprospect of this alliance is particularly attractive in India where IMVTechnologies' subsidiary is a respected market leader for theartificial insemination industry of the number one milk producer in theworld, involving 40 million dairy cows and 90 million buffalo."